OXYNORM 5MG CAPSULE,HARD

Country: Cyprus

Bahasa: Greek

Sumber: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

Download Ciri produk (SPC)
16-03-2018

Bahan aktif:

OXYCODONE HYDROCHLORIDE

Boleh didapati daripada:

MUNDIPHARMA PHARMACEUTICALS LTD (0000003104) 13 OTHELLOS STR, NICOSIA, 1685, 23661

Kod ATC:

N02AA05

INN (Nama Antarabangsa):

OXYCODONE

Dos:

5MG

Borang farmaseutikal:

CAPSULE,HARD

Komposisi:

OXYCODONE HYDROCHLORIDE (0000124903) 5MG BASE

Laluan pentadbiran:

ORAL USE

Jenis preskripsi:

Εθνική Διαδικασία

Kawasan terapeutik:

OXYCODONE

Ringkasan produk:

Νομικό καθεστώς: Με Ιατρική Συνταγή σύμφωνα με την Περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών Νομοθεσία; PACK WITH 56 CAPS IN BLISTER(S) (260012401) 56 CAPSULE - Εγκεκριμένο - Με Ιατρική Συνταγή σύμφωνα με την Περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών Νομοθεσία

Ciri produk

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
OxyNorm 5 mg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITIOIN
Each capsule contains 4.5 mg oxycodone as 5 mg of oxycodone
hydrochloride.
For excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Capsule, hard.
OxyNorm capsules 5 mg are orange/beige, printed ONR 5.
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For the treatment of moderate to severe pain in patients with cancer
and
post-operative pain. For the treatment of severe pain requiring the
use of a strong
opioid.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Route of administration:
Oral
In common with other strong opioids, the need for continued treatment
should be
assessed at regular intervals.
Elderly and adults over 18 years:
OXYNORM capsules should be taken at 4-6 hourly intervals. The dosage
is dependent
on the severity of the pain, and the patients previous history of
analgesic requirements.
Increasing severity of pain will require an increased dosage of
OxyNorm capsules.
The correct dosage for any individual patient is that which controls
the pain and is well
tolerated throughout the dosing period. Patients should be titrated to
pain relief unless
unmanageable adverse drug reactions prevent this.
The usual starting dose for opioid naive patients or patients
presenting with severe pain
uncontrolled by weaker opioids is 5 mg, 4-6 hourly. The dose should
then be carefully
titrated, as frequently as once a day if necessary, to achieve pain
relief. The majority of
patients will not require a daily dose greater than 400 mg. However, a
few patients may
require higher doses.
SPCONC01v2.02a
Patients receiving oral morphine before oxycodone therapy should have
their daily dose based
on the following ratio: 10 mg of oral oxycodone is equivalent to 20 mg
of oral morphine. It
must be emphasised that is a quide to the dose of OXYNORM capsules
required. Inter-patient
variability requires that each patient is carefully titrated to the
appropriate dose.
Controlled pharmacokinetic studies in elderly pat
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Inggeris 09-03-2024
Ciri produk Ciri produk Inggeris 01-03-2019

Cari amaran yang berkaitan dengan produk ini